Stephen Hoge

President

Cambridge, United States

Stephen Hoge, M.D., is President of Moderna, Inc., overseeing scientific research and clinical development, including the rapid advancement of COVID-19 vaccines. He joined Moderna in 2012 as Senior Vice President of Corporate Development after working as an emergency room physician in New York City. Hoge holds a medical degree and has been instrumental in leading Moderna’s antiviral mRNA vaccine programs. His expertise spans clinical development, medical research, and corporate strategy.

Expertise

• Leadership
• Clinical Development
• Medical Research
• Strategy
• Innovation